PRME
Prime Medicine, Inc.
Prime Medicine, Inc. (PRME) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 48.6, with 1/3 trend checks passing.
PRME with MA50 and MA200
Key levels & signals
Prime Medicine, Inc. (PRME) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $3.49, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 5.7% and below the 200-day moving average by 10.2%.
PRME currently has an RSI reading of 48.6, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.
This page is designed to help you quickly understand what the PRME chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.
About Prime Medicine, Inc.
Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their platform is the "Prime Editor" system, which combines a unique Prime Editor protein—a hybrid composed of a Cas protein and a reverse transcriptase enzyme—with a specialized pegRNA molecule. This pegRNA plays a crucial role by both guiding the Prime Editor to a precise location within the genome and providing the essential template for introducing the desired modification to the target DNA sequence. The company, founded in 2019, maintains its headquarters in Cambridge, Massachusetts.
Learn the indicators behind this page
More stock opportunities
Common questions about PRME
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.